GSK will sell Romanian plant

The UK-based pharmaceuticals group, GlaxoSmithKline (GSK), excluded its plant in Brasov from the global production chain citing over-production for solid oral formulas. The group will seek a buyer for the facility in the next six months. If a buyer is not found, the company will move its production to other plants, close its local facility and fire all the staff. This decision would be enforced by the second half of 2015,… Read More...